Prosus stock: fair value
PRX.ASThe fair value of Prosus under our model is $60.53, the price is 34% below.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $43.24 and expensive above $100.89 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $35.04 (cash-flow model) and $86.02 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 9.8%. At 10.8% the fair value would be $57.80, at 8.8% it would be $64.38.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (16.1).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 3.8%. Discounted at 9.8% (government bond yield 3.8% plus beta 1.41 times a risk premium of 4.2%); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $35.04 per share: free cash flow for the next ten years, each year discounted to today at 9.8%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 9.8%) |
|---|---|---|---|---|
| 2027 | $2.2B | extrapolated at 45.6% | 0.9107 | $2B |
| 2028 | $2.92B | extrapolated at 33.1% | 0.8293 | $2.42B |
| 2029 | $3.63B | extrapolated at 24.3% | 0.7553 | $2.74B |
| 2030 | $4.29B | extrapolated at 18.2% | 0.6878 | $2.95B |
| 2031 | $4.89B | extrapolated at 13.9% | 0.6264 | $3.06B |
| 2032 | $5.42B | extrapolated at 10.9% | 0.5704 | $3.09B |
| 2033 | $5.89B | extrapolated at 8.7% | 0.5195 | $3.06B |
| 2034 | $6.32B | extrapolated at 7.3% | 0.4731 | $2.99B |
| 2035 | $6.71B | extrapolated at 6.2% | 0.4308 | $2.89B |
| 2036 | $7.08B | extrapolated at 5.5% | 0.3924 | $2.78B |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $27.99B |
| Terminal value: cash flow 2036 × (1 + 3.8%) / (9.8% − 3.8%) | $123.03B |
| Present value of terminal value (× 0.3924) | $48.27B |
| Equity value (sum plus present value of terminal value) | $76.26B |
| Shares (diluted) | 2.18B |
| Value per share (equity value divided by shares) | $35.04 |
| Earnings per share, last twelve months | $5.36 |
| × 16.1 (industry P/E) | $86.02 |
| Fair value (average of both parts) | $60.53 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Oct 2021)
- Valuation signal Undervalued since 12 Nov 2026, previously Fairly valued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.